IP Library › Granted Patent US 6,994,995
Granted Patent B1
US 6,994,995 · App. 10/094,162 · Granted Feb 7, 2006

Human synaptotagmin and polynucleotides encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,994,995
App. No.
10/094,162
Granted
Feb 7, 2006
Kind
B1
Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims (7)

1. An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1.

2. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes the amino acid sequence shown in SEQ ID NO:2.

3. An isolated nucleic acid molecule according to claim 1 , wherein said nucleotide sequence is a cDNA sequence.

4. An isolated expression vector comprising the nucleic acid molecule of claim 2 .

5. The isolated expression vector of claim 4 , wherein said nucleic acid molecule comprises the nucleotide sequence of SEQ ID NO:1.

6. A host cell comprising the expression vector of claim 4 .

7. The host cell of claim 6 , wherein said nucleic acid molecule comprises the nucleotide sequence of SEQ ID NO:1.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →